Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
We are a biopharmaceutical company dedicated to developing innovative therapies that target the molecular mechanisms that cause cancer. Through our internal research programs and in conjunction with our collaborators, we are applying our expertise to develop and commercialize therapies designed... More
Other News & PR